Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tangzu Fang
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
Tangzu Fang (糖足方), also known as Tangzu Formula, is a traditional Chinese herbal medicine formula primarily investigated for the treatment of diabetic foot ulcers. It is often administered as granules for oral use or as an ointment for topical application, and is frequently used in conjunction with Western medicine. Research into its mechanism of action suggests it involves multiple chemical components that interact with various signaling pathways, potentially modulating inflammatory responses by affecting cytokines such as Interleukin-6 (IL-6) and Interleukin-1 beta (IL-1β).
- Other names
- 糖足方Tangzu Formula
02
Targets
IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Tangzu Fang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tangzu Fang.